Next-gen cell therapy manufacturing: leveraging flexibility and automation for success

Despite several cell therapy approvals, existing manufacturing capacity is inadequate to meet high patient demand. Automation is poised to play a crucial role in enhancing global patient access to these treatments. This article delves into the advanced technologies and automation strategies that are essential for navigating the evolving cell and gene therapy landscape, featuring insights from both the biopharma and tool provider sectors.

Please enter your email to access content Read now